13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Travere Therapeutics Inc. (TVTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 13,000,000 | $12,780,300 | 7.67% | ||
| 2. | 11,615,000 | $11,462,554 | -8% | 0.35% | |
| 3. | 1,377,000 | $1,351,652 | +34% | 0.03% | |
| 4. | 30,000 | $29,679 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.85 | 5,000 | $89,250.00 | 245,556 | 2017-06-14 | Filing | |
| $15.31 | 5,000 | $76,564.50 | 52,000 | 2016-03-04 | Filing | |
| $8.60 | 15,000 | $129,049.50 | 35,000 | 2014-11-25 | Filing | |
| $8.38 | 6,100 | $51,118.00 | 129,165 | 2014-11-21 | Filing | |
| $8.50 | 8,700 | $73,950.00 | 371,756 | 2014-11-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.65 | 815 | $11,939.75 | 88,787 | 2025-07-01 | Filing | |
| $21.05 | 1,784 | $37,553.20 | 93,126 | 2025-05-05 | Filing | |
| $21.05 | 18,924 | $398,350.20 | 419,173 | 2025-05-05 | Filing | |
| $21.05 | 1,771 | $37,279.55 | 128,215 | 2025-05-05 | Filing | |
| $21.05 | 3,198 | $67,317.90 | 100,241 | 2025-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | Css LlcBOND | 21,110,000 | $20,826,366 | 1.14% |
| 2. | 8,000 | $7,852,736 | 0.3% | |
| 3. | 1,040,000 | $1,030,294 | 0% | |
| 4. | 9,460,000 | $9,285 | 0.01% | |
| 5. | 0 | $0 | 0% |
News See All
Travere Therapeutics Kicks Off "Play It Forward" Campaign for FSGS Awareness
Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best biotech stocks to invest in now.
13 Best Biotech Stocks To Invest In Now
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
Travere Therapeutics, Inc. (NASDAQ:TVTX) is among the 10 Best Growth Stocks Under $100 to Buy Now.
10 Best Growth Stocks Under $100 to Buy Now
Even if asked by a layman where they would want to invest, the answer would be straight: growth stocks.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Travere Therapeutics First Quarter and Full Year 2025 Financial Results Conference Call. Today's call is being recorded.
10 Best Small-Cap Stocks to Buy Before They Explode
Since the announcement of tariffs, investors have been concerned regarding the market volatility.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. Today's call is being recorded.
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2024 Earnings Call Transcript
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2024 Earnings Call Transcript October 31, 2024Travere Therapeutics, Inc. misses on earnings expectations.
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
Billionaire Hedge Funds
